Pfizer Ltd, the Indian arm of the leading US pharmaceutical company, announced the appointment of Meenakshi Nevatia as its new Managing Director. Meenakshi will take up the role on April 3, 2023, for a five-year term, succeeding S. Sridhar, who retired earlier in August 2022.
With over 30 years of experience in business leadership and consulting across top companies such as McKinsey & Company and Novartis Pharmaceuticals, Meenakshi Nevatia brings a wealth of expertise to Pfizer Ltd. She has extensive global experience, having worked in eight countries, including developed and emerging markets, and held various General Management positions in countries such as Thailand, Spain, and India.
Meenakshi’s appointment is a significant event for the Indian pharmaceutical industry, as she takes the helm of one of the largest pharmaceutical companies in the country. With her vast experience in the industry and proven track record of success, Meenakshi is well-positioned to lead Pfizer Ltd into a new era of growth and innovation.
This appointment highlights the importance of diversity and inclusivity in the manufacturing industry and sends a positive message to the broader business community. Meenakshi’s experience and leadership style are sure to bring fresh perspectives and new ideas to Pfizer Ltd and help the company to continue to meet the evolving needs of its customers and stakeholders.
The Indian pharmaceutical industry is poised for significant growth in the coming years, and with Meenakshi at the helm, Pfizer Ltd is well-positioned to take advantage of these opportunities and drive continued success in the years to come.
